EMERYVILLE, Calif., March 11, 2013 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:AMRS), a leading renewable chemicals company, announced today it has joined Bonsucro, the world's leading sugarcane sustainability standard. Amyris is the first advanced biofuels and chemicals company of its kind to join Bonsucro, paving the way for certification of Amyris's renewable products.
" Amyris is committed to delivering No Compromise ® renewable products that enable sustainable growth for our customers. Bonsucro has emerged as a respected certification standard for sugarcane products, and membership paves the way for assuring our growing and diverse customer base of the sustainability of our supply chain," said Joel Velasco, Amyris's Senior Vice President.
" With our certification system recognized under the European Commission's Renewable Energy Directive and the 26 Bonsucro-certified sugarcane mills in Brazil, Bonsucro certified volumes are set to grow. We welcome Amyris's leadership to broaden the scope of second-generation renewable products that could be certified under Bonsucro," said Nick Goodall, Bonsucro's Chief Executive Officer.Bonsucro is a global multi-stakeholder, non-profit initiative focused on improving the social, environmental, and economic sustainability of the production of sugarcane. The Bonsucro Production Standard is used to certify — and assures buyers, suppliers and consumers that sugarcane-derived products meet — key sustainability indicators, such as energy consumption, greenhouse gas emissions and water consumption. Bonsucro members can demonstrate their commitment to sustainability by either procuring physical product or by purchasing through the Bonsucro Credit Trading System. About Amyris Amyris is an integrated renewable products company focused on providing sustainable alternatives to a broad range of petroleum-sourced products. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules—flexible building blocks that can be used in a wide range of products. Amyris's initial portfolio of commercial products is based on Biofene ®, Amyris's brand of renewable farnesene, a long-chain hydrocarbon. Amyris is commercializing these products both as No Compromise® renewable ingredients in cosmetics, flavors and fragrances, polymers, lubricants and consumer products, and also as No Compromise renewable diesel and jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the establishment and expansion of Amyris's production in Brazil. More information about Amyris is available at www.amyris.com . The Amyris, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12462 Forward-Looking Statements This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as achieving supply chain and production sustainability standards and the possibility of receiving Bonsucro certification) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays or failures in development, production or commercialization of products, liquidity and ability to fund capital expenditures, Amyris's reliance on third parties to achieve its goals, and other risks detailed in the "Risk Factors" section of Amyris's quarterly report on Form 10-Q filed on November 9, 2012. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts